E.J. Bodar

558 total citations
9 papers, 429 citations indexed

About

E.J. Bodar is a scholar working on Molecular Biology, Nephrology and Immunology. According to data from OpenAlex, E.J. Bodar has authored 9 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Nephrology and 3 papers in Immunology. Recurrent topics in E.J. Bodar's work include Inflammasome and immune disorders (6 papers), Immunodeficiency and Autoimmune Disorders (2 papers) and Gout, Hyperuricemia, Uric Acid (2 papers). E.J. Bodar is often cited by papers focused on Inflammasome and immune disorders (6 papers), Immunodeficiency and Autoimmune Disorders (2 papers) and Gout, Hyperuricemia, Uric Acid (2 papers). E.J. Bodar collaborates with scholars based in Netherlands, United States and Greece. E.J. Bodar's co-authors include J.W.M. van der Meer, Anna Simon, Joost P.H. Drenth, Jeroen C.H. van der Hilst, Joost Frenkel, Loes M. Kuijk, Mihai G. Netea, Evangelos J. Giamarellos‐Bourboulis, Maria Mouktaroudi and Barbara Kluve‐Beckerman and has published in prestigious journals such as Annals of the Rheumatic Diseases, Journal of Leukocyte Biology and Amyloid.

In The Last Decade

E.J. Bodar

9 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E.J. Bodar Netherlands	6	335	183	110	102	99	9	429
Evelien J. Bodar Netherlands	5	402 1.2×	214 1.2×	61 0.6×	187 1.8×	114 1.2×	8	469
Josefa Rius Spain	8	380 1.1×	245 1.3×	75 0.7×	143 1.4×	93 0.9×	8	528
R Barcellona Italy	4	301 0.9×	208 1.1×	46 0.4×	166 1.6×	63 0.6×	7	384
Emmanuelle Cochet France	7	607 1.8×	414 2.3×	98 0.9×	120 1.2×	97 1.0×	12	671
Fehime Kara Eroğlu Türkiye	11	263 0.8×	163 0.9×	95 0.9×	79 0.8×	56 0.6×	28	390
Özgül Soysal Türkiye	5	345 1.0×	173 0.9×	106 1.0×	57 0.6×	89 0.9×	8	400
Semanur Özdel Türkiye	9	231 0.7×	146 0.8×	84 0.8×	72 0.7×	65 0.7×	53	331
Nazife Şule Yaşar Bilge Türkiye	11	168 0.5×	94 0.5×	38 0.3×	39 0.4×	67 0.7×	38	284
M. Mısırlıoğlu Türkiye	10	325 1.0×	102 0.6×	86 0.8×	55 0.5×	32 0.3×	12	447
Makiko Yashiro Furuya Japan	9	106 0.3×	133 0.7×	27 0.2×	35 0.3×	103 1.0×	19	289

Countries citing papers authored by E.J. Bodar

Since Specialization

Citations

This map shows the geographic impact of E.J. Bodar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.J. Bodar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.J. Bodar more than expected).

Fields of papers citing papers by E.J. Bodar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E.J. Bodar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.J. Bodar. The network helps show where E.J. Bodar may publish in the future.

Co-authorship network of co-authors of E.J. Bodar

This figure shows the co-authorship network connecting the top 25 collaborators of E.J. Bodar. A scholar is included among the top collaborators of E.J. Bodar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E.J. Bodar. E.J. Bodar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Bodar, E.J., Loes M. Kuijk, Joost P.H. Drenth, et al.. (2011). On-demand anakinra treatment is effective in mevalonate kinase deficiency. Annals of the Rheumatic Diseases. 70(12). 2155–2158. 114 indexed citations

Bodar, E.J., et al.. (2009). Complete remission of severe idiopathic cold urticaria on interleukin-1 receptor antagonist (anakinra).. PubMed. 67(9). 302–5. 41 indexed citations

Hilst, Jeroen C.H. van der, E.J. Bodar, Joost Frenkel, et al.. (2008). Follow-up, clinical features, and quality of life in 10.3 patients with HyperImmunoglubulin D syndrome. Clinical and Experimental Rheumatology. 26(2). 180–180. 4 indexed citations

Giamarellos‐Bourboulis, Evangelos J., et al.. (2008). Crystals of monosodium urate monohydrate enhance lipopolysaccharide-induced release of interleukin 1β by mononuclear cells through a caspase 1-mediated process. Annals of the Rheumatic Diseases. 68(2). 273–278. 109 indexed citations

Hilst, Jeroen C.H. van der, Barbara Kluve‐Beckerman, E.J. Bodar, et al.. (2008). Lovastatin inhibits formation of AA amyloid. Journal of Leukocyte Biology. 83(5). 1295–1299. 15 indexed citations

Hilst, Jeroen C.H. van der, et al.. (2005). Serum amyloid A serum concentrations and genotype do not explain low incidence of amyloidosis in Hyper-IgD syndrome. Amyloid. 12(2). 115–119. 14 indexed citations

Bodar, E.J., Jeroen C.H. van der Hilst, Joost P.H. Drenth, J.W.M. van der Meer, & Anna Simon. (2005). Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model.. PubMed. 63(7). 260–4. 130 indexed citations

Bodar, E.J., Anna Simon, Jeroen C.H. van der Hilst, & Marcel van Deuren. (2004). Two patients with recurrent fever and wine red discolouration of the eyelids.. PubMed. 62(4). 119–20, 139. 1 indexed citations

Bree, Remco de, E.J. Bodar, Hans F. Mahieu, et al.. (2001). The value of the current diagnostic techniques and fluoro-18-deoxyglucose-positron emission tomography in suspicion of recurrent laryngeal carcinoma after radiotherapy. Clinical Otolaryngology. 26(4). 348–348. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact